Harbour Investments’s VanEck Pharmaceutical ETF PPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $391K | Buy |
4,450
+394
| +10% | +$34.7K | 0.01% | 870 |
|
|
2025
Q1 | $370K | Buy |
4,056
+532
| +15% | +$48.5K | 0.01% | 836 |
|
|
2024
Q4 | $304K | Buy |
3,524
+99
| +3% | +$8.54K | 0.01% | 864 |
|
|
2024
Q3 | $325K | Buy |
3,425
+488
| +17% | +$46.4K | 0.01% | 817 |
|
|
2024
Q2 | $269K | Buy |
2,937
+5
| +0.2% | +$457 | 0.01% | 834 |
|
|
2024
Q1 | $266K | Buy |
2,932
+1,275
| +77% | +$116K | 0.01% | 811 |
|
|
2023
Q4 | $135K | Buy |
1,657
+637
| +62% | +$51.8K | 0.01% | 1017 |
|
|
2023
Q3 | $81.5K | Hold |
1,020
| – | – | ﹤0.01% | 1125 |
|
|
2023
Q2 | $80.4K | Hold |
1,020
| – | – | ﹤0.01% | 1146 |
|
|
2023
Q1 | $79.2K | Hold |
1,020
| – | – | ﹤0.01% | 1150 |
|
|
2022
Q4 | $79.3K | Hold |
1,020
| – | – | ﹤0.01% | 1116 |
|
|
2022
Q3 | $78K | Hold |
1,020
| – | – | 0.01% | 1089 |
|
|
2022
Q2 | $78K | Buy |
+1,020
| New | +$78K | 0.01% | 1089 |
|
|
2021
Q4 | $79K | Sell |
1,020
-1,329
| -57% | -$103K | ﹤0.01% | 1071 |
|
|
2021
Q3 | $171K | Buy |
2,349
+5
| +0.2% | +$364 | 0.01% | 1104 |
|
|
2021
Q2 | $171K | Buy |
2,344
+7
| +0.3% | +$511 | 0.01% | 1123 |
|
|
2021
Q1 | $161K | Buy |
+2,337
| New | +$161K | 0.01% | 1072 |
|